Reuters
Japan began COVID-19 vaccinations for its sizable elderly population on Monday, with imported doses still in short supply and the pace unlikely to stop a fourth wave of infection. Shots for people aged 65 and above began at some 120 sites across the country, using Pfizer Inc's vaccine made in Europe and delivered to the regions in the past week. Just 2,810 people in Tokyo are expected to get a shot from the first batch, while most regions will receive 1,000 doses or fewer, according to a health ministry schedule.